CL2012003253A1 - Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico. - Google Patents

Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.

Info

Publication number
CL2012003253A1
CL2012003253A1 CL2012003253A CL2012003253A CL2012003253A1 CL 2012003253 A1 CL2012003253 A1 CL 2012003253A1 CL 2012003253 A CL2012003253 A CL 2012003253A CL 2012003253 A CL2012003253 A CL 2012003253A CL 2012003253 A1 CL2012003253 A1 CL 2012003253A1
Authority
CL
Chile
Prior art keywords
compounds
chalconas
trpv
alkylamides
thiadiazole
Prior art date
Application number
CL2012003253A
Other languages
English (en)
Inventor
Olavarria Miguel De La Cruz Zarraga
Ulloa Sebastian Esteban Brauchi
Rebolledo Carolyne Andrea Lespey
Original Assignee
Univ Concepcion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Concepcion filed Critical Univ Concepcion
Priority to CL2012003253A priority Critical patent/CL2012003253A1/es
Publication of CL2012003253A1 publication Critical patent/CL2012003253A1/es
Priority to PCT/CL2013/000085 priority patent/WO2014078971A1/es
Priority to US14/646,655 priority patent/US20160039778A1/en
Priority to EP13857010.6A priority patent/EP2924028A4/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/825—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups all hydroxy groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos derivados de 1,3,4-Tiadiazol Alquilamidas y de chalconas, antagonistas del receptor TRPV-1; uso de los compuestos para tratar el dolor crónico.
CL2012003253A 2012-11-22 2012-11-22 Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico. CL2012003253A1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CL2012003253A CL2012003253A1 (es) 2012-11-22 2012-11-22 Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.
PCT/CL2013/000085 WO2014078971A1 (es) 2012-11-22 2013-11-21 Compuesto antagonista del receptor trpv-1, derivados de 1,3,4-tiadiazol alquilamidas y de chalconas
US14/646,655 US20160039778A1 (en) 2012-11-22 2013-11-21 Trpv-1 receptor antagonist compound derived from 1,3,4-thiadiazole alkylamides and chalcones
EP13857010.6A EP2924028A4 (en) 2012-11-22 2013-11-21 TRPV-1-RECEPTORANTAGONIST COMPOUND FROM 1,3,4-THIADIAZOL ALKYLAMIDES AND CHALCONES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2012003253A CL2012003253A1 (es) 2012-11-22 2012-11-22 Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.

Publications (1)

Publication Number Publication Date
CL2012003253A1 true CL2012003253A1 (es) 2013-01-11

Family

ID=50775362

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003253A CL2012003253A1 (es) 2012-11-22 2012-11-22 Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.

Country Status (4)

Country Link
US (1) US20160039778A1 (es)
EP (1) EP2924028A4 (es)
CL (1) CL2012003253A1 (es)
WO (1) WO2014078971A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112694392B (zh) * 2020-12-21 2022-11-22 青岛大学 一种trpv3抑制剂及其制备方法
CN115105503B (zh) * 2022-07-20 2023-05-23 河南大学 一种trpv1拮抗/cox抑制双靶点药物或其药学上可接受的盐、药物制剂和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ231534A (en) * 1988-11-29 1992-02-25 Warner Lambert Co 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions
ATE489384T1 (de) * 2002-05-06 2010-12-15 Vertex Pharma Thiadiazole oder oxadiazole und ihre verwendung als jak proteinkinaseinhibitoren
JPWO2008007780A1 (ja) * 2006-07-13 2009-12-10 協和発酵キリン株式会社 ペンタジエナミド誘導体
WO2009090548A2 (en) * 2008-01-17 2009-07-23 Glenmark Pharmaceuticals, S.A. 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
US9096558B2 (en) * 2010-07-09 2015-08-04 Pfizer Limited N-sulfonylbenzamide compounds

Also Published As

Publication number Publication date
EP2924028A1 (en) 2015-09-30
EP2924028A4 (en) 2016-09-07
US20160039778A1 (en) 2016-02-11
WO2014078971A1 (es) 2014-05-30

Similar Documents

Publication Publication Date Title
CL2015002767A1 (es) Compuestos terapéuticos y composiciones
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
DOP2015000270A (es) Potenciador de inhibidores del homólogo de zeste
UA113440C2 (xx) Сполуки тетрагідропіразолопіримідину
CL2015000942A1 (es) Compuestos de benceno sustituido.
MX2016014308A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7.
CR20150472A (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRANSTORNOS RELACIONADOS CON LA PI3Kd
CL2016000153A1 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b
EA201691259A1 (ru) РЕГУЛЯТОРЫ Nrf2
MX2015011514A (es) Compuestos de heteroarilo y sus usos.
CR20150524A (es) Compuestos de heteroarilo y sus usos
TR201902516T4 (tr) Glukagon-glp-1-gıp üçlü agonist bileşikleri.
CL2015001377A1 (es) Inhbibidores de bmi-1 primidinas sustituidas inversas
PE20151436A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos
EA201490037A1 (ru) Антагонисты trpv4
MX2017001553A (es) Derivados de heterociclico opcionalmente condensados de pirimidina utiles para el tratamiento de enfermedades inflamatorias, metabolicas oncologicas y autoinmunitarias.
ECSP13012573A (es) 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3
CL2015002202A1 (es) Benzamidas sustituidas con actividad hacia receptores ep4.
ECSP16012582A (es) Compuestos heterocíclicos y métodos de uso
NI201500050A (es) Benzamidas
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
CR20160460A (es) Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados
MX387228B (es) Compuestos de pirazol como moduladores del receptor de hormona estimuladora de foliculo y sus usos.
ECSP16008797A (es) Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos
CR20140257A (es) Nuevos 2h-indazoles como antagonistas del receptor ep2